Large observational studies have found no association between GLP-1 receptor agonist use and pancreatic cancer
Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions
Ignoring expiry dates: Using expired medication may result in reduced efficacy or safety concerns
We combine clinical expertise with the convenience of telehealth to ensure you never have to navigate your weight loss journey alone
Adoption has moved beyond a niche patient group
Studies show that Semaglutide can lead to significant weight loss when combined with diet and exercise, offering women a practical way to manage their weight and feel more in control of their bodies during this transitional period. Metabolic Health Improvements: Supporting Blood Sugar and Heart Health In addition to weight gain, hormonal changes during menopause can affect blood sugar levels and increase the risk of metabolic syndromea collection of conditions, including high blood pressure, high blood sugar, and abnormal cholesterol levels, that increase the risk of heart disease, stroke, and diabetes. Semaglutides impact on blood sugar control can be particularly beneficial for menopausal women, as it helps stabilize blood glucose and reduces insulin resistance